Bacil Pharma
Bacil Pharma Share Price Chart
Bacil Pharma last traded at ₹24.50 (2026-10-13). Over the past month the stock moved +31.9%, three months the stock moved -51.8%, year the stock moved -39.3%. Its closing range over 52 weeks is ₹11.20 – ₹59.89, with the latest close 59.1% below the high.
Closing prices up to 2026-10-13.
About Bacil Pharma
Incorporated in 1987, Bacil Pharma Ltd is in Pharmaceutical business[1]
Operational Status:[1] Company is non operational for the past many years. It has not carried out any major business activity and management is considering diversifying their business activities and have deployed surplus funds as temporary loans and advances
Fundamentals
Quarterly Results
In the latest quarter (Jun 2026), Bacil Pharma reported sales of ₹0.00 crore and net profit of ₹-0.02 crore (-103.0%), compared with the same quarter last year.
| Period | Sales | Operating profit | OPM % | Net profit | EPS (₹) |
|---|---|---|---|---|---|
| Jun 2026 | 0.00 | -0.02 | – | -0.02 | -0.01 |
| Mar 2026 | 0.00 | -0.07 | – | 0.62 | 0.43 |
| Dec 2025 | 0.00 | -0.02 | – | 0.04 | 0.03 |
| Sep 2025 | 0.00 | -0.03 | – | 0.01 | 0.01 |
| Jun 2025 | 0.00 | -0.11 | – | 0.67 | 0.47 |
| Mar 2025 | 0.00 | -0.07 | – | 0.02 | 0.01 |
| Dec 2024 | 0.00 | -0.06 | – | -0.06 | -0.10 |
| Sep 2024 | 0.00 | -0.07 | – | 0.48 | 0.81 |
| Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 | |
|---|---|---|---|---|---|---|---|---|
| Sales growth | – | – | – | – | – | – | – | – |
| Operating profit growth | – | – | – | – | – | – | – | – |
| Net profit growth | – | – | – | – | -97.9% | – | +3000.0% | -103.0% |
| EPS growth | – | – | – | – | -98.8% | – | +4200.0% | -102.1% |
| OPM % | – | – | – | – | – | – | – | – |
Colour scale: below -5% -5% to 0% 0% to 5% 5% to 20% 20% and above. A dash means the earlier figure was zero or negative, so a percentage is not meaningful.
Annual Financials
In the latest year (Mar 2026), Bacil Pharma reported sales of ₹0.00 crore and net profit of ₹1.56 crore (+290.0%), compared with the previous year.
| Period | Sales | Operating profit | OPM % | Net profit | EPS (₹) |
|---|---|---|---|---|---|
| Mar 2026 | 0.00 | -0.25 | – | 1.56 | 1.09 |
| Mar 2025 | 0.00 | -0.25 | – | 0.40 | 0.28 |
| Mar 2024 | 0.00 | -0.19 | – | -0.06 | -0.10 |
| Mar 2023 | 0.00 | -0.17 | – | -0.10 | -0.17 |
| Mar 2022 | 0.00 | -0.16 | – | -3.86 | -6.55 |
| Mar 2021 | 0.00 | -0.16 | – | -0.24 | -0.41 |
| Mar 2020 | 0.00 | -0.18 | – | -0.32 | -0.54 |
| Mar 2019 | 0.00 | -0.26 | – | -0.34 | -0.58 |
| Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|---|---|
| Sales growth | – | – | – | – | – | – | – | – |
| Operating profit growth | – | – | – | – | – | – | – | – |
| Net profit growth | – | – | – | – | – | – | – | +290.0% |
| EPS growth | – | – | – | – | – | – | – | +289.3% |
| OPM % | – | – | – | – | – | – | – | – |
Colour scale: below -5% -5% to 0% 0% to 5% 5% to 20% 20% and above. A dash means the earlier figure was zero or negative, so a percentage is not meaningful.
Shareholding
AI Analysis
No AI analysis generated yet for Bacil Pharma.
Get Free AI Stock Analysis FREE →Latest News
-
Bacil Pharma CS Dikshant Singh Panwar resigns effective Oct 8 - scanx.trade
-
Bacil Pharma CS Dikshant Singh Panwar resigns effective Oct 8 - scanx.trade
-
Bacil Pharma Q1 Results: Net profit turns to loss of ₹1.61 lakh - scanx.trade
-
Bacil Pharma reports standalone net loss of Rs 0.02 crore in the June 2026 quarter - Business Standard
Frequently Asked Questions
What is the share price of Bacil Pharma today?
Bacil Pharma shares were last quoted at ₹24.50 (-1.1% on the day). Use the Refresh price button on this page for the latest available price. Prices are for information only.
What is the P/E ratio of Bacil Pharma?
Bacil Pharma has a price-to-earnings (P/E) ratio of 57.11 and a price-to-book (P/B) ratio of 1.50. The industry P/E is 53.33.
What is the 52-week high and low of Bacil Pharma?
The 52-week high of Bacil Pharma is ₹61.80 and the 52-week low is ₹10.65.
What is the market cap of Bacil Pharma?
The market capitalisation of Bacil Pharma is about ₹37.71 crore.
How did Bacil Pharma perform in its latest quarterly results?
In the latest quarter (Jun 2026), Bacil Pharma reported sales of ₹0.00 crore and net profit of ₹-0.02 crore (-103.0%), compared with the same quarter last year.
Is Bacil Pharma a good stock to buy?
This page is for information and is not investment advice. As per the data shown here, Bacil Pharma has a 3-year ROE of 3.00%, 3-year profit growth of 131.00%. Review the fundamentals, quarterly results and AI analysis on StockSpin, and consult a SEBI-registered adviser before investing.
What is the promoter holding in Bacil Pharma?
Promoters hold about 0.08% of Bacil Pharma.
Which sector does Bacil Pharma belong to?
Bacil Pharma belongs to the Pharmaceuticals & Drugs sector.